相关实验视频

Updated: Jun 25, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

将免疫疗法推向可切除非小细胞肺癌的治疗

Jamie E Chaft¹, Rafal Dziadziuszko², Bernardo Haddock Lobo Goulart³

¹Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

|May 24, 2024

概括

免疫检查点抑制剂 (ICI) 越来越多地用于早期非小细胞肺癌 (NSCLC). 目前正在进行研究,以优化它们与手术和放射治疗一起使用,解决治疗选择和疗效的关键知识差距.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胸部外科手术胸部外科手术

背景情况:

免疫检查点抑制剂 (ICI) 现在正在研究早期和可切除的非小细胞肺癌 (NSCLC),扩展到转移性指示之外.
随机试验已经支持ICI批准术前使用 (辅助剂,新辅助剂),目前正在进行的研究正在探索与刻板体辐射疗法 (SBRT) 的组合.

研究的目的:

审查NSCLC当前局部治疗标准.
描述结合ICI与SBRT的临床试验.
解释最近ICI批准的外科手术期间的NSCLC治疗.
要突出关键的领域的不确定性在外科手术期间免疫治疗可切除的NSCLC.

主要方法:

审查已完成和正在进行的临床试验,涉及ICI在NSCLC的外科设置.
对NSCLC局部疗法的当前治疗标准的分析.
讨论知识缺口和未来的研究方向.

主要成果:

ICI在改善可切除NSCLC的结果方面表现有希望.
免疫治疗的整合增加了治疗的复杂性,并引入了知识差距.
不确定性的具体领域包括ICI在不同外科手术前阶段的贡献,试验的比较者选择,以及病理完整反应的作用.

结论:

切除性NSCLC的最佳管理需要进一步的研究,以解决围绕术后免疫治疗的临床问题.
需要所有利益相关者的协同研究努力,以确定在这种环境中最佳使用ICI.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...